- Home
- EP vs CHRS Comparison
EP vs CHRS Comparison
Compare EP & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EP
- CHRS
- Stock Information
- Founded
- EP 1983
- CHRS 2010
- Country
- EP United States
- CHRS United States
- Employees
- EP N/A
- CHRS N/A
- Industry
- EP Oil & Gas Production
- CHRS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EP Energy
- CHRS Health Care
- Exchange
- EP Nasdaq
- CHRS Nasdaq
- Market Cap
- EP 169.9M
- CHRS 185.5M
- IPO Year
- EP N/A
- CHRS 2014
- Fundamental
- Price
- EP $6.14
- CHRS $1.52
- Analyst Decision
- EP
- CHRS Strong Buy
- Analyst Count
- EP 0
- CHRS 4
- Target Price
- EP N/A
- CHRS $5.38
- AVG Volume (30 Days)
- EP 37.3K
- CHRS 10.1M
- Earning Date
- EP 11-14-2024
- CHRS 11-06-2024
- Dividend Yield
- EP N/A
- CHRS N/A
- EPS Growth
- EP N/A
- CHRS N/A
- EPS
- EP N/A
- CHRS N/A
- Revenue
- EP $43,254,386.00
- CHRS $304,340,000.00
- Revenue This Year
- EP N/A
- CHRS $1.64
- Revenue Next Year
- EP N/A
- CHRS $16.98
- P/E Ratio
- EP N/A
- CHRS N/A
- Revenue Growth
- EP 10.97
- CHRS 44.19
- 52 Week Low
- EP $4.06
- CHRS $0.66
- 52 Week High
- EP $10.99
- CHRS $3.70
- Technical
- Relative Strength Index (RSI)
- EP 37.53
- CHRS 52.47
- Support Level
- EP $6.26
- CHRS $1.45
- Resistance Level
- EP $7.20
- CHRS $1.85
- Average True Range (ATR)
- EP 0.36
- CHRS 0.23
- MACD
- EP -0.17
- CHRS -0.03
- Stochastic Oscillator
- EP 0.00
- CHRS 3.88
About EP Empire Petroleum Corporation
Empire Petroleum Corp is a conventional oil and natural gas producer with a main focus in the US onshore. The company possesses long-life, mature, producing assets with slow decline profiles in the Permian Basin, Bakken region and central Gulf Coast region, in the states of New Mexico, North Dakota, Montana, Louisiana and Texas. It has production from operated and non-operated wells in Lea County in New Mexico, Bottineau, Renville, Burke, and McKenzie Counties in North Dakota, Richland County in Montana, St. Landry, Beauregard Parishes in Louisiana and Houston, Leon and Madison Counties in Texas.
About CHRS Coherus BioSciences Inc.
Coherus BioSciences Inc is a commercial-stage biopharmaceutical company building an immuno-oncology franchise funded with cash generated by its diversified portfolio of FDA-approved therapeutics. The company is focused on the research, development, and commercialization of its portfolio of FDA-approved oncology products, including LOQTORZI. The company markets UDENYCA, a biosimilar of Neulasta in the United States, and expects to launch the FDA-approved Humira biosimilar YUSIMRY in the United States in 2023. The company generates revenue from the United States.